Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-22

FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for ALEVE GELCAPS (naproxen sodium) by Bayer HealthCare LLC., expanding the product through a supplemental approval to t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALEVE GELCAPS (NAPROXEN SODIUM)

Snippet

SUPPL AP for ALEVE GELCAPS (NAPROXEN SODIUM)